ITGAE and neoplasm: The combination treatment-expanded CD103+ DCs were able to engulf cellular debris from OVV-exposed ID8-T cells at higher levels compared with their virotherapy-expanded counterparts (Figure 4D; p ≤ 0.04), which is stringently required for mounting an immune response against dying tumor cells.8